Planet Briefing

First published · Last updated

Early adoption of lecanemab in Japan (December 2023–December 2024): Pretreatment diagnostic timelines from the DeSC claims database

Journal article reports on early adoption of lecanemab in Japan between December 2023 and December 2024, examining pretreatment diagnostic timelines using the DeSC claims database. The supplied excerpt contained only publication metadata and no further study details.

[Kazusa Kanōzan] / Hiroshige-ga.
Illustrative image: [Kazusa Kanōzan] / Hiroshige-ga. — Andō, Hiroshige, 1797-1858/Library of Congress, Free to Use and Reuse

Categories: public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
3/10
Geographic reach
4/10
Global importance
3/10
Impact magnitude
4/10
Positivity
6/10
Urgency
2/10

Why it matters

The study concerns real-world adoption of a therapeutic agent in Japan and may inform health-sector stakeholders.

Location

Sources

Report an issue